Suppr超能文献

药物依从性对医疗保险星级评定的影响:对健康计划绩效的十年分析。

The influence of medication adherence on Medicare Star Ratings: A decade-long analysis of health plan performance.

作者信息

Borrelli Eric P, Saad Peter, Barnes Nathan, Lucaci Julia D

机构信息

Health Economics and Outcomes Research, Medication Management Solutions (MMS), Becton, Dickinson and Company, San Diego, CA.

Medical Affairs, MMS, Becton, Dickinson and Company, Durham, NC.

出版信息

J Manag Care Spec Pharm. 2025 May;31(5):512-519. doi: 10.18553/jmcp.2025.31.5.512.

Abstract

BACKGROUND

The Medicare Star Ratings Program, managed by the Centers for Medicare & Medicaid Services, assesses Medicare health plan performance. This program consists of quality measures that evaluate plan performance for both Medicare Part C and Part D, including 3 key medication adherence measures.

OBJECTIVE

To assess the potential relationship between performance on medication adherence measures and overall star rating performance for Medicare Advantage (MA) health plans.

METHODS

An analysis was conducted using annual Medicare Star Rating health plan performance data from 2015 to 2024 to assess the impact of performance on medication adherence measures on health plan overall star rating. Numerical percentages were calculated to assess the rates of a health plan achieving at least a 4-star overall rating if they achieved 4 or more stars, as well as a 5-star rating on each medication adherence measure or composite measure.

RESULTS

From 2015 to 2024, 4,213 health plan contracts received a star rating, of which 2,076 achieved at least a 4-star overall rating (49.3%). For plans achieving at least 4 stars on the medication adherence measures, 70%-74% of them also achieved at least a 4-star overall summary rating, depending on the specific measure. Among plans achieving 5 stars on any adherence measure, 85%-90% of them achieved at least a 4-star overall rating.

CONCLUSIONS

Assessing a decade of the Medicare Star Rating performance data showed that MA health plans that performed well on the medication adherence measures also had a high rate of achieving a 4-star overall rating. Future research should explore the interplay between medication adherence measures and other Medicare Star Rating criteria.

摘要

背景

由医疗保险和医疗补助服务中心管理的医疗保险星级评定计划评估医疗保险健康计划的表现。该计划包括评估医疗保险C部分和D部分计划表现的质量指标,其中包括3项关键的药物依从性指标。

目的

评估医疗保险优势(MA)健康计划在药物依从性指标上的表现与总体星级评定表现之间的潜在关系。

方法

利用2015年至2024年的年度医疗保险星级评定健康计划表现数据进行分析,以评估药物依从性指标表现对健康计划总体星级评定的影响。计算了数字百分比,以评估健康计划在每项药物依从性指标或综合指标上获得4星及以上评级时,获得至少4星总体评级的比例,以及获得5星评级的比例。

结果

2015年至2024年,4213份健康计划合同获得了星级评定,其中2076份(49.3%)获得了至少4星的总体评级。对于在药物依从性指标上获得至少4星的计划,根据具体指标,其中70%-74%的计划也获得了至少4星的总体综合评级。在任何一项依从性指标上获得5星的计划中,85%-90%的计划获得了至少4星的总体评级。

结论

对十年医疗保险星级评定表现数据的评估表明,在药物依从性指标上表现良好的MA健康计划获得4星总体评级的比例也很高。未来的研究应探讨药物依从性指标与其他医疗保险星级评定标准之间的相互作用。

相似文献

1
The influence of medication adherence on Medicare Star Ratings: A decade-long analysis of health plan performance.
J Manag Care Spec Pharm. 2025 May;31(5):512-519. doi: 10.18553/jmcp.2025.31.5.512.
2
Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
J Manag Care Spec Pharm. 2014 Dec;20(12):1193-203. doi: 10.18553/jmcp.2014.20.12.1193.
3
A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior.
J Manag Care Spec Pharm. 2016 May;22(5):526-38. doi: 10.18553/jmcp.2016.22.5.526.
4
Evaluation of Comprehensive Medication Review Completion Rates Using 3 Patient Outreach Models.
J Manag Care Spec Pharm. 2016 Jul;22(7):796-800. doi: 10.18553/jmcp.2016.22.7.796.
7
Is There a Relationship Between Part D Medication Adherence and Part C Intermediate Outcomes Star Ratings Measures?
J Manag Care Spec Pharm. 2016 Jul;22(7):787-95. doi: 10.18553/jmcp.2016.22.7.787.
8
Is there an association between the high-risk medication star ratings and member experience CMS star ratings measures?
J Manag Care Spec Pharm. 2014 Nov;20(11):1129-36. doi: 10.18553/jmcp.2014.20.11.1129.
10
Association between Medicare Advantage plan star ratings and enrollment.
JAMA. 2013 Jan 16;309(3):267-74. doi: 10.1001/jama.2012.173925.

本文引用的文献

1
Racial and ethnic disparities related to the Medicare Part D Medication Therapy Management Program.
J Manag Care Spec Pharm. 2024 Jun;30(6):609-616. doi: 10.18553/jmcp.2024.30.6.609.
2
Medication adherence star ratings measures, health care resource utilization, and cost.
Am J Manag Care. 2024 May;30(5):210-217. doi: 10.37765/ajmc.2024.89538.
3
Comprehensive Medication Review Completion Rates and Disparities After Medicare Star Rating Measure.
JAMA Health Forum. 2024 May 3;5(5):e240807. doi: 10.1001/jamahealthforum.2024.0807.
4
A primer on quality measurement and reporting in pharmacy benefit plans.
J Manag Care Spec Pharm. 2024 Apr;30(4):386-396. doi: 10.18553/jmcp.2024.23240. Epub 2024 Mar 1.
5
Association of medication adherence quality measures for diabetes, hypertension, and hyperlipidemia with cognitive decline.
J Family Med Prim Care. 2023 Nov;12(11):2667-2675. doi: 10.4103/jfmpc.jfmpc_935_23. Epub 2023 Nov 21.
6
Building health plan-pharmacist provider partnerships to optimize medication outcomes.
J Manag Care Spec Pharm. 2023 Dec;29(12):1284-1289. doi: 10.18553/jmcp.2023.29.12.1284.
7
Effects of star ratings bonus payments on disparities in medication utilization issues.
Explor Res Clin Soc Pharm. 2023 Aug 22;11:100323. doi: 10.1016/j.rcsop.2023.100323. eCollection 2023 Sep.
8
Effects of Part D Star Ratings on racial and ethnic disparities in health care costs.
Explor Res Clin Soc Pharm. 2023 Mar 24;9:100250. doi: 10.1016/j.rcsop.2023.100250. eCollection 2023 Mar.
9
Impact of star ratings on Medicare health plan enrollment: A systematic literature review.
J Am Pharm Assoc (2003). 2023 Jul-Aug;63(4):989-997.e3. doi: 10.1016/j.japh.2023.03.009. Epub 2023 Apr 3.
10
Association between medication adherence and health-related quality of life of patients with diabetes.
Hormones (Athens). 2022 Dec;21(4):691-705. doi: 10.1007/s42000-022-00400-y. Epub 2022 Oct 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验